Abstract
Implantable cardioverter defibrillators (ICD) are automatic arrhythmia management devices designed to detect ventricular tachycardia (VT), fast ventricular tachycardia (FVT) or ventricular fibrillation (VF) and, upon detection, deliver the programmed pacing cardioversion or defibrillation therapies. In addition these devices provide bradycardia pacing therapy. An ICD constantly monitors the cardiac rhythm for adequate short-term therapy delivery by means of one lead in the right ventricle and, only in dual chamber ICDs, another lead in the right atrium. When an event occurs, the ICD measures its amplitude. The sensitivity is automatically adjusted on the basis of the measured amplitude until a new event is sensed at the end of the absolute refractory period. Heart rhythm detection is usually based on the classification of R-R intervals into three classes: slow rhythm (SR), ventricular tachycardia and ventricular fibrillation. The ICD makes this classification by measuring the R-R interval and comparing it to programmable boundaries: VT and VF cycle length. Ventricular tachycardia detection occurs when the corresponding R-R interval is longer than the VF cycle length and shorter than or equal to the VT cycle length, and the cumulative number of VT detections are equal to a programmed parameter (NVT). Ventricular fibrillation detection occurs when the corresponding R-R interval is shorter than or equal to the VF cycle length and the cumulative number of VF detections are equal to a programmed parameter (NVF). Sinus rhythm detection occurs when the corresponding R-R interval is longer than the VT and VF cycle lengths. The treatment to apply in case of an SR detection or VF detection is unambiguous. However, a VT detection can indeed be: sinus tachycardia, supraventricular tachycardia (atrial fibrillation, flutter or atrial tachycardia) or ventricular tachycardia. In order to distinguish between them, single chamber ICDs adopt dedicated algorithms. If tachycardia is detected ICD delivers pulse burst or ramp for antitachycardia stimulation or cardioversion therapy via the combined pacing/sensing/shock electrode.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schmitt C., Bracmann J., Waldecker B.et al, Implantable cardioverter defibrillator: possible hazards of electromagnetic interference. Pacing and Clinical Electrophysiology. 14: 6, 982–4 (1991).
Seifert T., Block M., Breithardt G., Erroneous discharge of an implantable cardioverter defibrillator caused by an electric razor Pacing and Clinical Electrophysiology. 18: 8, 1592–4 (1995).
Madrid A., Sànchez A., Bosch E.et al., Dysfunction of implantable defibrillators caused by slot machine. Pacing and Clinical Electrophysiology. 20: 1 Pt2, 212–214 (1997).
McIvor M.E., Environmental electromagnetic interference from electronic article surveillance devices: interaction with an ICD. Pacing and Clinical Electrophysiology. 18: 2229–2230 (1995).
Fetter J.G., Rpee, Benditt D.G. et al., Electromagnetic interference from welding and motors on implantable cardioverter defibrillator as tested in the electrically hostile work site. JACC. 28: 2, 423–427 (1996).
Man K. C., Davidson R., Langberg J.J. et al., Interferences from a hand held radio frequency remote control causing discharge of an implantable defibrillator. Pacing and Clinical Electrophysiology. 16: 1756–1758 (1993).
Hayes D.L., Carrillo R.G., Findlay G.F., Embrey M., State of the science: pacemaker and defibrillator interference from wireless communication devices. Pacing and Clinical Electrophysiology. 19: 1419–30 (1996)
Bassen H. I., Moore H. J., Ruggera P. S., Cellular phone interference testing of implantable defibrillators, in-vitro. Circulation. 92, 8: 738 (1995).
Bostrom U., Interference from mobile telephone a challenge for clinical engineers. Clinical Engineering Update. 10: 1–2 (1991).
Barbaro V., Bartolini P., Donato A. et al. Electromagnetic interference of analog cellular telephones with pacemaker. Pacing and Clinical Electrophysiology. 19: 1410–1418 (1996).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Barbaro, V. et al. (1999). GSM Cellular Phones Interference with Implantable Ventricular Defibrillators. In: Bersani, F. (eds) Electricity and Magnetism in Biology and Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4867-6_177
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4867-6_177
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7208-0
Online ISBN: 978-1-4615-4867-6
eBook Packages: Springer Book Archive